Page last updated: 2024-11-04

vorinostat and Erectile Dysfunction

vorinostat has been researched along with Erectile Dysfunction in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Erectile Dysfunction: The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lee, J1
Cho, MC1
Son, H1
Kim, SW1

Other Studies

1 other study available for vorinostat and Erectile Dysfunction

ArticleYear
Restoring erectile function by combined treatment with JNK inhibitor and HDAC inhibitor in a rat model of cavernous nerve injury.
    Andrology, 2022, Volume: 10, Issue:4

    Topics: Animals; Caspase 3; Disease Models, Animal; Erectile Dysfunction; Fibronectins; Fibrosis; Histone De

2022